4ALBRECHT T,BlOMLEY M,BOLONDI L,et al.Guidelines for the use of contrast agents in ultrasound[J].Ultraschall Med,2004,25(4):249-256.
5KUMADA T,NAKANO S,TOYODA H,et al.Assessment of tumor hemodynamics in small hepatocellular carcinoma:comparison of Doppler ultrasonography,angiography-assisted computed tomography,and pathological findings[J].Liver International,2004,24(5):425-431.
6BRUIX J,SHERMAN M.Management of hepatocellular carcinoma[J].Hepatology,2005,42(5):1208-1236.
7QUAIA E,CALLIADA F,BERTOLOTTO M,et al,Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent:diagnostic performance and confidence[J].Radiology,2004,232(2):420-430.
8COSGROVE D.Ultrasound contrast agents:an overview[J].European Journal of Radiology,2006,60(3):324-330.
9KRIX M,KIESSLING F,ESSIG M,et al.Low mechanical index contrast-enhanced ultrasound better reflects high arterial perfusion of liver metastases than arterial phase computed tomography[J].Invest Radio,2004,39(4):216-222.
10Wilsion SR,Jang HJ,Kim TK,et al.Diagnosis of focal liver masses on ultrasonography:comparision of unenhanced and contrast-enhanced scans[J].J Ultrasound Med,2007,26(6):785-787.
